RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Rapid City, SD · +55 more sites
4 recruiting obesity studies with a site in Rapid City, SD.
Sponsor: AstraZeneca
Rapid City, SD · +55 more sites
Sponsor: Amgen
Rapid City, SD · +139 more sites
Sponsor: Novo Nordisk A/S
Rapid City, SD · +33 more sites
Sponsor: Amgen
Rapid City, SD · +120 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.